Cite
Discovery of a potential biomarker for immunotherapy of melanoma: PLAC1 as an emerging target.
MLA
Mahmoudi, Ahmad-Reza, et al. “Discovery of a Potential Biomarker for Immunotherapy of Melanoma: PLAC1 as an Emerging Target.” Immunopharmacology & Immunotoxicology, vol. 42, no. 6, Dec. 2020, pp. 604–13. EBSCOhost, https://doi.org/10.1080/08923973.2020.1837865.
APA
Mahmoudi, A.-R., Ghods, R., Rakhshan, A., Madjd, Z., Bolouri, M.-R., Mahmoudian, J., Rahdan, S., Shokri, M.-R., Dorafshan, S., Shekarabi, M., & Zarnani, A.-H. (2020). Discovery of a potential biomarker for immunotherapy of melanoma: PLAC1 as an emerging target. Immunopharmacology & Immunotoxicology, 42(6), 604–613. https://doi.org/10.1080/08923973.2020.1837865
Chicago
Mahmoudi, Ahmad-Reza, Roya Ghods, Azadeh Rakhshan, Zahra Madjd, Mohammad-Reza Bolouri, Jafar Mahmoudian, Shaghayegh Rahdan, et al. 2020. “Discovery of a Potential Biomarker for Immunotherapy of Melanoma: PLAC1 as an Emerging Target.” Immunopharmacology & Immunotoxicology 42 (6): 604–13. doi:10.1080/08923973.2020.1837865.